A recent study, published in the journal Nature looked into the six-month impact of switching neovascular age-related macular degeneration and diabetic macular oedema patients to faricimab instead of anti-VEGF therapy.
Researchers at the Perelman School of Medicine at the University of Pennsylvania have reported improvements in vision among patients with a rare inherited condition, following gene therapy.
A groundbreaking new tool, The Glaucoma Field Defect Classifier (GFDC), developed by eye specialists at Addenbrooke’s Hospital, could transform glaucoma diagnosis and help change the way its managed worldwide.
Researchers from UCL and Moorfields Eye Hospital have identified potential markers in the blood that could change the treatment of glaucoma, a leading cause of irreversible blindness worldwide.
In a new effort to revolutionise treatment for eye injuries and disorders, a team of researchers from the University of Liverpool have secured £2.1 million in funding.
Myopia has a significant economic and societal impact globally, and its prevalence in the digital age is increasing. We discuss the causes, symptoms and treatment for this condition.
Antonia Chitty, Head of Communications and IT at the Association of British Dispensing Opticians, provides insight into sustainable eyewear and eye care procurement.
Diabetic retinopathy is the real medical term for diabetic eye disease. It is the most common cause of blindness in people of working age. 94 million people are affected worldwide.
